Celestica, Inc (CLS) concluded trading on Thursday at a closing price of $129.78, with 3.85 million shares of worth about $499.68 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 153.53% during that period and on February 13, 2025 the price saw a gain of about 0.36%. Currently the company’s common shares owned by public are about 116.36M shares, out of which, 115.70M shares are available for trading.
Stock saw a price change of -2.58% in past 5 days and over the past one month there was a price change of 25.87%. Year-to-date (YTD), CLS shares are showing a performance of 40.61% which increased to 239.38% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $36.00 but also hit the highest price of $144.27 during that period. The average intraday trading volume for Celestica, Inc shares is 3.44 million. The stock is currently trading 7.91% above its 20-day simple moving average (SMA20), while that difference is up 23.11% for SMA50 and it goes to 86.85% higher than SMA200.
Celestica, Inc (NYSE: CLS) currently have 116.36M outstanding shares and institutions hold larger chunk of about 76.35% of that.
The stock has a current market capitalization of $15.10B and its 3Y-monthly beta is at 2.19. PE ratio of stock for trailing 12 months is 34.60, while it has posted earnings per share of $3.75 in the same period. It has Quick Ratio of 0.91 while making debt-to-equity ratio of 0.42. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CLS, volatility over the week remained 6.50% while standing at 7.94% over the month.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Stifel on February 04, 2025 offering a Buy rating for the stock and assigned a target price of $140 to it. Coverage by CIBC stated Celestica, Inc (CLS) stock as a Sector outperform in their note to investors on January 31, 2025, suggesting a price target of $150 for the stock. On November 22, 2024, UBS Initiated their recommendations, while on November 05, 2024, Barclays Initiated their ratings for the stock with a price target of $91. Stock get a Buy rating from Stifel on September 09, 2024.
